Drilling Fills Gaps Between Resource Pits at Gold Project
Source: Rabi Nizami   (9/4/22)
New results from this area between two deposits show greater widths and consistent grades when compared to previously reported intercepts from there, noted a National Bank of Canada report. More >

Will Pharma Co. Keep Pushing Higher After Full Data Set Released on Lung Disease Study?
Source: Streetwise Reports  (9/4/22)
One small-cap pharma co. just published more good news on a possible treatment for patients suffering from idiopathic pulmonary fibrosis, a lung disease that's usually terminal. Find out why the company has more near-term catalysts and may continue to build on an 84% gain since a private placement in mid-August. More >

Mining Co. Proves Two Gold Zones Connected
Source: Jonathan Egilo  (9/3/22)
New drill results from this Idaho project also showed there is at-surface mineralization of higher grades than the average of the current resource, noted a Desjardins report. More >

Results Point to Bulk Mining Potential at Idaho Gold Project
Source: Streetwise Reports  (9/2/22)
Drill results from Liberty Gold Corp.’s flagship Black Pine project in Idaho show that the site’s largest areas of concentrated gold are connected. More >

Denmark Co. To Buy US Biopharma Co. for $1.1 Billion
Source: Streetwise Reports  (9/2/22)
Forma Therapeutics Holdings Inc. shares traded 51% higher yesterday after the company reported it agreed to be acquired by Denmark's Novo Nordisk A/S in an all-cash deal for $20.00 per share. With the acquisition, Novo Nordisk aims to expand its global presence in the treatment of rare blood disorders and sickle cell disease. More >

B.C. Mining Explorer To Start Trading on CSE Sept. 6
Source: Streetwise Reports  (9/2/22)
The company is in the process of meeting its obligations to earn 100% of a Vancouver Island property that is prospective for precious and base minerals . . . and sasquatches. More >

Oil & Gas Producer Benefits from Surge in Natural Gas Prices
Source: Streetwise Reports  (9/2/22)
Shares of Trillion Energy International Inc. traded 14% higher to a new 52-week high after the company reported it has increased the price it receives for natural gas by 47% to US$31/Mcf. More >

'No End in Sight' Yet of Gold System at Idaho Asset
Source: Geordie Mark  (9/1/22)
New drill results highlight intra-pit continuity of mineralization and resource expansion potential, noted a Haywood Securities report. More >

Expert Rates Pharma Co. An Immediate Buy
Source: Chris Temple  (9/1/22)
Expert Chris Temple gives his view on Algernon Pharmaceuticals stock in light of its positive results for its Phase 2a study for the treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Rare Earths Explorer Looks to Challenge China
Source: Streetwise Reports  (8/31/22)
This Canadian explorer is working toward a preliminary feasibility study at its Wicheeda rare earth element deposit in British Columbia. More >

Helium Co. With Acquisition in Progress Draws Attention
Source: Anish Kapadia  (8/31/22)
Hannam & Partners launched coverage on this near-term producing company set to add proven helium assets in Alberta to its large helium property portfolio in Saskatchewan. More >

Silver Miner Set to Yield 'Robust Cash Flow,' Expert Says
Source: Stephen Soock  (8/31/22)
Despite the increase in cost assumptions for the company's joint venture project in Mexico, this mining company is positioned for "robust cash flow," noted a Stifel report. More >

Uranium Co. With Big Upside as the Sector Takes Off
Source: Clive Maund  (8/31/22)
In light of the world moving away from fossil fuels, expert Clive Maund reviews Azincourt Energy Corp.'s six-month, three-year, and 12-month charts to tell you whether he believes it is a Buy. More >

ChargePoint Boosts Network Charging Revenue by 106%
Source: Streetwise Reports  (8/31/22)
ChargePoint Holdings Inc. shares traded 14% higher after the company reported Q2/23 financial results that included a 93% YoY increase in revenue. The firm posted the first $100 million sales quarter in its history and affirmed its FY/23 revenue guidance for total revenues of $450-$500 million. More >

Silver Junior Opening New Plant in Mexico Is 'Top Pick'
Source: Streetwise Reports  (8/30/22)
At least nine analysts continue to rate MAG Silver Corp. a Buy after positive second-quarter financials, even as it continues to wait for its electricity hookup at its new plant in Mexico. More >

Argentina Lithium Raises Cash to Buy Properties, Advance Exploration
Source: Streetwise Reports  (8/30/22)
With a 340% year-over-year increase in the price of lithium, raising cash for exploration is easier than it once was. One lithium junior just raised more than CA$3.3 million to bolster its lithium portfolio with another project in Argentina and continues exploration on a nearby project that borders a lithium project being developed by Rio Tinto. More >

FDA OKs Biopharma to Trial New Cell Therapy
Source: Mitchell Kapoor  (8/30/22)
Now with clearance, the firm plans to commence a Phase 1 study of its lead candidate in patients with lymphoma by the end of this year, noted an H.C. Wainwright & Co. report. More >

Royal Helium Ltd. News Ought To Get It Moving
Source: Clive Maund  (8/30/22)
Expert Clive Maund reviews the most recent news with Royal Helium Ltd., which has just signed a new supply agreement with a major space launch company. More >

Mining Co. Makes Progress Toward Needed Designation
Source: Mike Kozak  (8/30/22)
A project site visit revealed the explorer is working to achieve this goal, necessary for an environmental certificate extension, Cantor Fitzgerald noted in a report. More >

Pharma Co. Plans IND Filing for Dry Eye Disease Drug in Q4/22
  (8/30/22)
Shares of OKYO Pharma Ltd. traded 23% higher after the company reported it intends to submit an IND to the U.S. FDA for its OK-101 for treating dry eye disease in Q4/22. Together with its manufacturing partner, AmbioPharm Inc., the firm is now preparing to initiate a phase 2 clinical study in Q1/23. More >

Delay in New Drug Filing Now Could Yield Benefits Later
Source: Hartaj Singh  (8/29/22)
The developer of genetic medicines is taking six more months to conduct longer preclinical safety studies involving its lead therapeutic, noted an Oppenheimer report. More >

ACC Recommends Approved Drug for Lowering LDL
Source: Joseph Pantginis  (8/29/22)
This same medicine is currently being evaluated in a global clinical trial from which topline results are expected in Q1/23, noted an H.C. Wainwright & Co. report. More >

Space Launch Co. Signs Offtake With Helium Explorer
Source: Streetwise Reports  (8/29/22)
One helium company in western Canada slated to launch helium production in Q1/23 just signed a helium offtake agreement with a 'space launch company.' Find out the name of the helium company and why its helium operations have a low carbon footprint. More >

Pharma Co. To Provide HHS With Smallpox Drug
Source: Streetwise Reports  (8/29/22)
Chimerix Inc. shares traded 8% higher after the company reported it has entered into a 10-year, $680 million contract with a U.S. Government health agency to deliver up to 1.7 million treatment courses of its TEMBEXA for use as a medical countermeasure for smallpox. More >

Helium E&P Lands Offtake Agreement with Space Launch Co.
Source: Phil Skolnick   (8/29/22)
With this first such agreement and derisking milestone for the energy company, it "is expected to realize near-term cash flows," noted an Eight Capital report. More >